Ming Luo
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer Cells and Metastasis
Papers in
-
- RNA Research and Splicing 8
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 4
-
- Cancer-related molecular mechanisms research 10
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Max S. Wicha (14 shared papers)Jun‐Lin Guan (4 shared papers)Marc Peters‐Golden (9 shared papers)Thomas G. Brock (9 shared papers)Yigang Zeng (2 shared papers)Wei Wang (2 shared papers)Zuowei Li (2 shared papers)Jianxin Qiu (2 shared papers)
- Journals
- Cancer Research (6 papers)Journal of Biological Chemistry (6 papers)Clinical and Experimental Hypertension (2 papers)Cells (2 papers)Cancer Letters (2 papers)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Ming Luo
78 papers receiving 4.0k citations
Ming Luo's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 1.3k
- Oncology 1.2k
- Immunology and Allergy 267
- Molecular Biology 2.0k
- Immunology 511
Countries citing papers authored by Ming Luo
This map shows the geographic impact of Ming Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Luo more than expected).
Fields of papers citing papers by Ming Luo
This network shows the impact of papers produced by Ming Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Luo. The network helps show where Ming Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts Hit paper breakdown → | 2010 | 589 |
| 2 | 2013 | 472 | |
| 3 | 2018 | 280 | |
| 4 | 2009 | 240 | |
| 5 | 2005 | 206 | |
| 6 | 2009 | 174 | |
| 7 | 2015 | 168 | |
| 8 | 2013 | 124 | |
| 9 | 2003 | 115 | |
| 10 | 2021 | 111 | |
| 11 | 2004 | 103 | |
| 12 | 2019 | 103 | |
| 13 | 2015 | 87 | |
| 14 | 2005 | 72 | |
| 15 | 2012 | 67 | |
| 16 | 2018 | 66 | |
| 17 | 2021 | 50 | |
| 18 | 2013 | 49 | |
| 19 | 2023 | 48 | |
| 20 | 2011 | 46 |
About Ming Luo
Ming Luo is a scholar working on Molecular Biology, Cancer Research, Oncology, Cardiology and Cardiovascular Medicine and Surgery, having authored 83 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (13 papers), Cancer-related molecular mechanisms research (10 papers), RNA Research and Splicing (8 papers), Cell Adhesion Molecules Research (5 papers), RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Epigenetics and DNA Methylation (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.2k citations), Immunology and Allergy (267 citations), Molecular Biology (2.0k citations) and Immunology (511 citations). Ming Luo has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Max S. Wicha, Jun‐Lin Guan, Marc Peters‐Golden, Thomas G. Brock, Yigang Zeng, Wei Wang, Zuowei Li, Jianxin Qiu, Zhihong Liu and Suling Liu. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Clinical and Experimental Hypertension, Cells and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.